Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/08/2001WO2001083756A1 Method for obtaining plants exhibiting enhanced resistance to water stress
11/08/2001WO2001083754A2 Cellular regulators of infectious agents and methods of use
11/08/2001WO2001083753A2 Molecules of the nbs/lrr protein family and uses thereof
11/08/2001WO2001083752A2 23949 and 32391, human ion channels and uses thereof
11/08/2001WO2001083751A2 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001WO2001083748A1 Novel g protein-coupled receptor protein and dna thereof
11/08/2001WO2001083747A2 Prion proteins and their uses
11/08/2001WO2001083746A2 Regulatory nucleic acid sequences of the abc1 gene
11/08/2001WO2001083745A1 New gtpase-activating protein 1
11/08/2001WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001WO2001083743A1 A novel polypeptide, a human red blood cell adducin alpha subunit 11 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083742A1 A novel polypeptide, a human pax protein 11.7 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083741A1 A novel polypeptide, a myb human protein 10 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083739A2 Human pellino polypeptides
11/08/2001WO2001083738A1 Sex determinative differentiation regulatory factor
11/08/2001WO2001083737A2 Porcine adenovirus type 5 vector and vaccine
11/08/2001WO2001083736A2 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof
11/08/2001WO2001083732A2 Databases of regulatory sequences; methods of making and using same
11/08/2001WO2001083730A2 Recombinant lentiviral vectors pseudotyped in envelopes containing filovirus binding domains
11/08/2001WO2001083728A1 A novel polypeptide - human excitatory amino acid transporter 9 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083705A1 Myocardial cell proliferation-associated genes
11/08/2001WO2001083703A2 Checkpoint-activating oligonucleotides
11/08/2001WO2001083701A2 Light-driven energy generation using proteorhodopsin
11/08/2001WO2001083699A2 Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
11/08/2001WO2001083697A2 System for functional gene discovery in plants
11/08/2001WO2001083695A2 Dna sequences encoding dystrophin minigenes and methods of use thereof
11/08/2001WO2001083693A2 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
11/08/2001WO2001083687A2 A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083686A2 Novel polypeptide, a human inclusion-like protein 9 and polynucleotide encoding it
11/08/2001WO2001083685A2 A novel polypeptide, a cap protein 10 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083684A2 A novel polypeptide, a human zinc-finger krab kraz2-13 protein and the polynucleotide encoding the polypeptide
11/08/2001WO2001083683A2 A novel polypeptide, a human pax protein 11.3 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083682A2 A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083679A2 A novel polypeptide- central cannabinoid recptor 9 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083677A2 A novel polypeptide- human chiken limb deformity protein fh12-13 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001WO2001083561A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses
11/08/2001WO2001083559A2 Production and use of protein variants having modified immunogenecity
11/08/2001WO2001083558A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
11/08/2001WO2001083557A1 A novel polypeptide, a cellular factor receptor 10 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083556A2 Retina xr receptor
11/08/2001WO2001083555A2 Pain signaling molecules
11/08/2001WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001WO2001083553A2 G protein-coupled receptors
11/08/2001WO2001083552A2 Human sez6 nucleic acids and polypeptides
11/08/2001WO2001083551A1 Reagent for detection of biomolecules, and use thereof
11/08/2001WO2001083550A2 Gpr22 modulators as appetite-control agents
11/08/2001WO2001083549A2 Novel polypeptides constituting pheromone receptors in rats, cloning and use thereof
11/08/2001WO2001083548A1 Novel derivative of cell chemotactic factor
11/08/2001WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001WO2001083546A1 THE CaR RECEPTOR AS A MEDIATOR OF MIGRATORY CELL CHEMOTAXIS AND/OR CHEMOKINESIS
11/08/2001WO2001083545A1 Novel proetin and use thereof
11/08/2001WO2001083544A1 A novel polypeptide, a human pax protein 18 and the polynucleotide encoding the polypeptide
11/08/2001WO2001083543A1 Human wingless-like gene
11/08/2001WO2001083542A1 A novel polypeptide, human p18 protein 21 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083541A1 A novel polypeptide-human kruppel associated dna binding protein 42 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083540A1 A novel polypeptide-kiaa0883-44 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083538A1 A novel polypeptide, a human k-ras gene protein 36 and the polynucleotide
11/08/2001WO2001083536A1 A novel polypeptide-cytokine receptor 15 and the polynucleotide encoding said polypeptide
11/08/2001WO2001083535A2 Polypeptides for use as a vaccine and/or treatment for hiv infection
11/08/2001WO2001083534A1 Anti-freeze proteins, their production and use
11/08/2001WO2001083533A1 Helicobacter pylori antigens: fusion of hpaa and hpa44
11/08/2001WO2001083532A1 Helicobacter pylori antigens: fusion of fay 31 and hpa 44
11/08/2001WO2001083531A1 Method for identifying helicobacter antigens
11/08/2001WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001WO2001083528A2 Nucleic acid immunization
11/08/2001WO2001083527A2 Glucagon antagonists
11/08/2001WO2001083526A2 Calcitonin-related molecules
11/08/2001WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001WO2001083524A2 Rna metabolism proteins
11/08/2001WO2001083523A2 Stmst protein and nucleic acid molecules and uses therefor
11/08/2001WO2001083522A2 Growth factor modified protein matrices for tissue engineering
11/08/2001WO2001083519A1 ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF
11/08/2001WO2001083518A2 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
11/08/2001WO2001083516A1 Laminin 15 and uses thereof
11/08/2001WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001WO2001083510A1 29 human secreted proteins
11/08/2001WO2001083506A1 Human abc1 promoter and assays based thereon
11/08/2001WO2001083504A1 Colon carcinoma related polynucleotides
11/08/2001WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001WO2001082962A2 Immunizing against hiv infection
11/08/2001WO2001082957A1 Snthetic vaccine for tick control
11/08/2001WO2001082948A2 Uses of tgap7 for the modulation of leucocyte activation
11/08/2001WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001WO2001082943A2 Subcutaneous administration of coagulation factor vii
11/08/2001WO2001082870A2 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
11/08/2001WO2001082862A2 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/08/2001WO2001082788A2 Compounds and methods for the treatment and prevention of bacterial infection
11/08/2001WO2001082688A1 Rab GDI alpha KNOCKOUT ANIMALS
11/08/2001WO2001058493A8 Conjugates of follicle stimulating hormones
11/08/2001WO2001046229A8 Cytokine family member, mature 2-21
11/08/2001WO2001042279A3 Complementary peptide ligands generated from plant genomes
11/08/2001WO2001042278A3 Complementary peptide ligands generated from microbial genome sequences
11/08/2001WO2001041801A3 Mutant simplex virus for treating unwanted hyperproliferative cell growth
11/08/2001WO2001040490A3 Eukaryotic initiation factor 4e inhibitors and their use as herbicides
11/08/2001WO2001040460A8 Screening method for compounds capable of modularing egr-1-regulated expression
11/08/2001WO2001038872A3 Assay of isomerised and/or optically inverted proteins
1 ... 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 ... 2916